INTERPACE BIOSCIENCES, INC. (IDXGD) Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock

INTERPACE BIOSCIENCES, INC. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock

INTERPACE BIOSCIENCES, INC. (IDXGD) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock of 2.44 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock · last filed 2026-08-10

• INTERPACE BIOSCIENCES, INC. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2026-03-31 was 4.91M shares, a 78.89% decline year-over-year.
• INTERPACE BIOSCIENCES, INC. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2025-09-30 was 23.27M shares.
• INTERPACE BIOSCIENCES, INC. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2025-03-31 was 23.27M shares.
• INTERPACE BIOSCIENCES, INC. incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2025 was 23.27M shares, a 105.68% increase from fiscal 2024.
• INTERPACE BIOSCIENCES, INC. incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2024 was 11.31M shares.